The current work extends these mechanistic observations to geriatric AF pathophysiology, demonstrating its capacity to orchestrate NAD+ metabolic rejuvenation via dual modulation of Nampt-mediated biosynthesis and PARP1-dependent catabolism. The gene discussed is PARP1; the disease is atrial fibrillation.